Indefinite Delivery Contract 75F40121D00032

Award Date 9/23/21
Last Date to Order 9/29/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ihrc, Incorporated, a small disadvantaged and woman-owned business. The $49.5 million contract provides the FDA with specialized technical services to support safety, occupational health, and laboratory operations across its facilities. Key services include safety engineering, industrial hygiene, laboratory science, laboratory security, and occupational health support. The...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
The indefinite delivery contract (IDC) HHSF223201710066C was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Mississippi State Department of Health (MSDH) Finance & Accounts Division. The single-award IDC has a ceiling value of $617,617.33 and an ultimate completion date of July 22, 2022. It is for MQSA (Mammography Quality Standards Act) inspections, which support the FDA's mission of overseeing the safety and quality of medical devices. Under this...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Mpza LLC, a minority and women-owned small business. The contract has a ceiling value of $40,000,000 and a period of performance through May 2028. The primary purpose of this IDC is to provide data management program support services for the FDA Adverse Event Reporting System (FAERS). This includes processing a backlog of adverse event reports, as well as ongoing data...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Heitech Services, LLC, a woman-owned and service-disabled veteran-owned small business. The contract has a ceiling value of $112,953,739.38 and a period of performance from September 1, 2008 to August 31, 2014. The contract provides for a range of document processing, data entry, and administrative support services for the FDA's Center for Drug Evaluation and Research...
The indefinite delivery contract (IDC) HHSF223200910022C was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the non-profit organization America's Poison Centers. The $2,258,661 single-award contract, which has an ultimate completion date of September 27, 2012, aims to provide the FDA with the "Availability of National Level Poisoning Data in the United States for the Identification and Understanding" through America's Poison Centers' National Poison...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $6,785,460 through September 30, 2029, awarded by the U.S. Food and Drug Administration (FDA) to the Missouri Department of Mental Health's Division of Behavioral Health. The contract is focused on tobacco retail compliance and enforcement inspections in the state of Missouri, including recruiting and training underage purchasers, coordinating undercover buy operations at tobacco retailers,...
  • 75F40121D00032
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances.

Two task orders have been issued under this IDC. The first is a $1,046,568.62 firm-fixed price delivery order to conduct a study understanding the "Prevalence, Experiences, Knowledge, and Perceptions of Falsified and Unapproved Pharmaceuticals in an Enriched Population Being Assessed for or Entering Substance Use Disorder Treatment." The second is a $1,024,971 firm-fixed price delivery order to provide data resources and six-month surveillance reports on non-medical use of pharmaceuticals and use of illicit drug substances, with a period of performance through September 2026. Neither task order has a small business set-aside.

Generated 12/12/24, 9:10 AM